Corton Capital Inc. Xencor Inc Transaction History

Corton Capital Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$18.65 - $26.52 $20,999 - $29,861	1,126 Added 3.39%	34,336 $759,000
Q4 2023 Feb 14, 2024	BUY	$16.53 - $21.42 $548,961 - $711,358	33,210 New	33,210 $705,000
Q2 2022 Aug 15, 2022	SELL	$19.74 - $29.01 $205,690 - $302,284	-10,420 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$26.68 - $41.63 $15,581 - $24,311	-584 Reduced 5.31%	10,420 $278,000
Q4 2021 Feb 14, 2022	BUY	$33.67 - $43.44 $370,504 - $478,013	11,004 New	11,004 $441,000

215

71.5M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.44B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Corton Capital Inc. with notifications on news.